Form 4: Compass Pathways Director Granted 52,000 Share Options
Insider Transaction Report
Jeffrey M. Jonas, a Director at COMPASS Pathways plc, was granted 52,000 share options with an exercise price of $6.33, vesting over three years.
Summary
- Jeffrey M. Jonas, a Director of COMPASS Pathways plc (CMPS), was granted 52,000 share options.
- The transaction date for this grant was October 29, 2025.
- Each share option has an exercise price of $6.33.
- The options will vest in 36 equal monthly installments over three years.
- The first tranche of options will vest and become exercisable on November 29, 2025.
- The options have an expiration date of October 28, 2035.
- Following this transaction, Jeffrey M. Jonas beneficially owns 52,000 derivative securities (share options).
Sentiment
Score: 6
Explanation: Slightly positive, as it indicates continued alignment of a director's interests with long-term shareholder value, a common and generally accepted practice in corporate governance.
Positives
- The grant of share options to a director aligns management's interests with those of shareholders, incentivizing long-term company performance.
- The vesting schedule over three years encourages sustained commitment and performance from the director.
Negatives
- The grant of options does not represent an immediate cash investment by the director.
- Future exercise of these options could lead to dilution for existing shareholders, although this is a common mechanism for executive compensation.
Risks
- The value of the options is dependent on the future market price of COMPASS Pathways plc's ordinary shares, which can fluctuate.
- If the share price does not exceed the exercise price of $6.33, the options may not be in-the-money and could expire worthless.
- Market volatility and company-specific performance could impact the ultimate value realized from these options.
Future Outlook
The grant of these options suggests an expectation of future growth and value creation for COMPASS Pathways plc, as the options' value is tied to the company's stock performance over the next decade.
Industry Context
This is a routine insider transaction (Form 4) reporting an equity grant to a director, common practice across industries to incentivize leadership. It does not provide specific insights into broader industry trends or competitive positioning.
Stakeholder Impact
- Shareholders: Potential for increased alignment of director's interests with long-term shareholder value. Future exercise could lead to minor dilution.
Next Steps
- The options will continue to vest in 36 equal monthly installments over three years, with the first vesting on November 29, 2025.
Key Dates
| Date | Description |
|---|---|
| 10/29/2025 | Date of transaction where share options were acquired. |
| 11/29/2025 | Date when the first tranche of options will vest and become exercisable. |
| 10/28/2035 | Expiration date of the share options. |
Keywords
COMPASS Pathways, CMPS, Share Options, Director Grant, Insider Transaction, SEC Form 4, Equity Compensation, Jeffrey M. Jonas
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.